Vitamin and fatty-acid supplement study for COPD recovery
Part of Lungs & breathing clinical trials.
This trial tests whether a targeted supplement (vitamins D and fatty acids) can help people with COPD. It’s meant for people who are medically stable and not currently dealing with a recent COPD flare-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (COPD and healthy control groups).
- If you have COPD, your disease is moderate to very severe (GOLD stage II to IV).
- You are medically stable and not recently hospitalized.
- You can follow the supplement plan and you’re willing to stop other vitamin D/fatty-acid supplements during the study.
- You do not have a known allergy or intolerance to the study supplement ingredients.
- You have no history in the past 5 years of lung cancer, and no dementia or recent brain-related diagnoses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with COPD (chronic lung disease) over many years to better understand the condition. It may help doctors learn what factors predict worsening over time.
This trial tests whether vitamin C supplements can improve health in people with COPD. It aims to see if the antioxidant effects of vitamin C help manage the disease and slow its progression.
This trial tests whether increasing omega-3 (from diet and/or supplements) helps people with COPD. It enrolls people with low omega-3 intake and asks them to follow a specific dietary plan during the study.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
This study looks at how inflammation and oxidative stress affect COPD. It tests whether a pulmonary rehabilitation program helps reduce these factors in people with stable COPD who are former smokers.
This trial studies cardiovascular (heart and blood vessel) risk in people who have stable COPD or a recent worsening of COPD. It may help researchers understand which risks to monitor during and after a COPD flare and how to prevent complications.
Hear when a new Pulmonary Disease, Chronic Obstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.